4
Changes in Ownership
Lantern Pharma Inc. Filed Acc 0001493152-25-014612
Options or other derivatives
- Chief Financial Officer acquired 104,400 shares (grant or award)
- Chief Financial Officer returned 104,400 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Margrave David R. · Chief Financial Officer
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-06-15 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −78,300 | 0 | D |
| 2020-06-15 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +78,300 | 78,300 | D |
| 2021-10-29 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −26,100 | 0 | D |
| 2021-10-29 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +26,100 | 26,100 | D |
Loading xslF345X05/ownership.xml…